Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
davoceticept (ALPN-202)
i
Other names:
ALPN-202, ALPN 202
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Alpine Immune Sci
Drug class:
CTLA4 antagonist, CD28 stimulant, PD-L1 antagonist
Related drugs:
‹
AGEN1181 (4)
UGN-301 (2)
JS007 (0)
TBio-6517 (0)
NILK-3301 (0)
INBRX-105 (0)
ATG-101 (0)
AGEN1181 (4)
UGN-301 (2)
JS007 (0)
TBio-6517 (0)
NILK-3301 (0)
INBRX-105 (0)
ATG-101 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login